ketanserin has been researched along with mdl 100907 in 145 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (5.52) | 18.2507 |
| 2000's | 66 (45.52) | 29.6817 |
| 2010's | 63 (43.45) | 24.3611 |
| 2020's | 8 (5.52) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J | 1 |
| Barrett, RJ; Sanders-Bush, E; Smith, RL | 1 |
| Carr, AA; Johnson, MP; Siegel, BW | 1 |
| López-Giménez, JF; Mengod, G; Palacios, JM; Vilaró, MT | 4 |
| Aloyo, VJ; Harvey, JA; Hoffman, ME; Salt, GL | 1 |
| Caldarola-Pastuszka, M; DeLashaw, M; Uphouse, L; Wolf, A | 1 |
| Chen, K; De Maeyer, E; Kung, MP; Meehan, WP; Ridd, MJ; Seif, I; Shih, JC | 1 |
| Adlersberg, M; Arango, V; Hsiung, S; Kassir, SA; Liu, K; Mann, JJ; Ruggiero, DA; Tamir, H; Underwood, MD | 1 |
| Cunningham, KA; McMahon, LR | 1 |
| Fantegrossi, WE; Godlewski, T; Karabenick, RL; Rice, KC; Stephens, JM; Ullrich, T; Woods, JH | 1 |
| Cunningham, KA; Filip, M; McCreary, AC | 1 |
| Grasby, P; Hirani, E; Hume, S; Sharp, T; Sprakes, M | 1 |
| Holland, PJ; Johnson, MS; Lutz, EM; Mitchell, R; Moggach, LO; Robertson, DN | 1 |
| Fink, GD; Li, MW; Ni, W; Thakali, K; Watts, SW | 1 |
| Bailer, UF; Barbarich, NC; Brooks-Achenbach, S; Frank, GK; Henry, SE; Kaye, WH; Mathis, CA; McConaha, CW; Meltzer, CC; Price, JC; Weissfeld, L | 1 |
| Goto, F; Obata, H; Saito, S; Sakurazawa, S; Sasaki, M; Usui, T | 1 |
| Blake, BL; Breese, GR; Knapp, DJ; Papadeas, ST | 1 |
| Hirano, S; Kamei, J; Miyata, S | 1 |
| Dubreuil, B; Guilbert, F; Herbert, JM; Janiak, P; Lainée, P; McCort, G; O'Connor, SE | 1 |
| Caldwell, DP; Levin, ED; Rezvani, AH | 1 |
| Jacono, FJ; Kumar, GK; Peng, YJ; Prabhakar, NR | 1 |
| Cao, YX; Edvinsson, L; He, LC; Luo, GG; Xu, CB | 1 |
| Lutterschmidt, DI; Mason, RT | 1 |
| Asgari, K; Body, S; Bradshaw, CM; Fone, KC; Rickard, JF; Szabadi, E; Zhang, Z | 1 |
| Angers, P; Dalbó, S; Jürgensen, S; Ribeiro-do-Valle, RM; Santos, AR | 1 |
| Gorzalka, BB; Hill, MN; Sun, JC | 1 |
| Bourin, M; Dailly, E; Hascoët, M; Masse, F | 1 |
| da Silva, SP; de Almeida, RM; de Oliveira, VP; Giovenardi, M; Stein, DJ | 1 |
| Matsumoto, K; Morishige, R; Murakami, Y; Sakakibara, I; Takayama, H; Tohda, M; Watanabe, H | 1 |
| Fujii, H; Hirai, T; Nishio, H; Nitanda, A; Tokumo, K; Yasunami, N | 1 |
| Elfving, B; Gillings, N; Knudsen, GM; Kristiansen, H; Pinborg, LH; Plenge, P | 1 |
| Jazvinsćak Jembrek, M; Lazić, J; Pericić, D; Svob Strac, D | 1 |
| Asgari, K; Bak, VK; Body, S; Bradshaw, CM; Fone, KC; Glennon, JC; Rickard, JF; Szabadi, E; Zhang, ZQ | 1 |
| Chapman, ME; Wideman, RF | 1 |
| Kajos, M; Kankaanpää, A; Meririnne, E; Seppälä, T | 1 |
| Günther, S; Maroteaux, L; Schwarzacher, SW | 1 |
| Bernard, JF; Comet, MA; Hamon, M; Laguzzi, R; Sévoz-Couche, C | 1 |
| Crespo, MJ; Dunbar, DC; Quidgley, J | 1 |
| Elfrey, JE; Finkelman, FD; Madden, KB; Morimoto, M; Shea-Donohue, T; Urban, JF; Zhao, A | 1 |
| Kuypers, KP; Ramaekers, JG; Wingen, M | 2 |
| Harris, MB; Kober, AM; Leiter, JC; St-John, WM; Toppin, VA | 1 |
| Alexandropoulou, KN; Demonakou, MD; Hereti, RI; Kourentzi, KT; Manta, GA; Mykoniatis, MG; Panoutsopoulos, GI; Papadimas, GK; Skaltsas, SD; Tzirogiannis, KN | 1 |
| Ni, CR; Shen, FM; Su, DF; Wang, J; Wang, WZ; Yu, JG | 1 |
| Aranda, E; Downey, P; Giacaman, A; Mezzano, D; Romero, W; Salas, SP; Vío, CP | 1 |
| Chang, FC; Lin, CP; Lin, JG; Tsai, CH; Yi, PL | 1 |
| Birkeland, JA; Enger, U; Levy, FO; Lunde, PK; Qvigstad, E; Sejersted, OM; Sjaastad, I; Swift, F; Tovsrud, N | 1 |
| Fletcher, PJ; Higgins, GA; Sinyard, J; Tampakeras, M | 1 |
| Carter, OL; Hasler, F; Liu, GB; Pettigrew, JD; Vollenweider, FX; Wallis, GM | 1 |
| Ballabeni, V; Barocelli, E; Bertoni, S; Cattaruzza, F; Ghizzardi, P; Impicciatore, M; Lagrasta, CA; Tognolini, M | 1 |
| Leiter, JC; St-John, WM | 1 |
| Debus, F; Herth, MM; Knudsen, GM; Lüddens, H; Palner, M; Piel, M; Rösch, F | 1 |
| Harmar, AJ; Jennings, KA; Sharp, T; Sheward, WJ | 1 |
| Agrawal, AK; Bhattamisra, SK; Khanna, VK; Singh, PN; Singh, SK | 1 |
| Chemel, BR; Frescas, SP; Lewin, AH; Nichols, DE; Rehder, KS; Zhong, D | 1 |
| Baumeister, AA; Hawkins, MF; Hearn, JK; Uzelac, SM | 1 |
| Atwood, WJ; Lane, TE; O'Hara, BA; Schaumburg, C | 1 |
| Ahmad, R; Egerton, A; Grasby, PM; Hirani, E | 1 |
| Bras, H; Coulon, P; Gaytán, SP; Hilaire, G; Pásaro, R; Portalier, P; Zanella, S | 1 |
| Horton, K; Johnson, M; Levin, ED; Petro, A; Rezvani, AH; Rose, JE; Slade, S; Williams, P | 1 |
| Becnel, J; Johnson, O; Nichols, CD | 1 |
| Araki, H; Cui, R; Li, B; Suemaru, K; Tanaka, M; Watanabe, S | 1 |
| France, CP; Li, JX; Rice, KC | 1 |
| Bianchi, P; Calise, D; Escourrou, G; Galinier, M; Guilbeau-Frugier, C; Lairez, O; Mialet-Perez, J; Ordener, C; Parini, A; Pizzinat, N; Roncalli, J; Seif, I; Spreux-Varoquaux, O | 1 |
| Anju, TR; George, AK; Paulose, CS | 1 |
| Huang, X; Krishnamoorthy, S; Ma, Z; Tao, R; Vukovich, NP; Zhang, G | 1 |
| Hadamitzky, M; Koch, M | 1 |
| France, CP; Javors, MA; Koek, W; Li, JX; Rice, KC; Unzeitig, A | 1 |
| Nakamichi, K; Nukuzuma, C; Nukuzuma, S; Takegami, T | 1 |
| Becker, T; Feja, M; Hadamitzky, M; Koch, M | 1 |
| Anselmo-Franci, JA; Bícego, KC; de Souza Moreno, V; Gargaglioni, LH; Szawka, RE | 1 |
| Doyle, JR; Yamamoto, BK | 1 |
| Bullich, S; Catafau, AM; Farre, M; Gunn, RN; Herance, R; Laruelle, M; Rabiner, EA; Radua, J; Searle, GE | 1 |
| le Grand, SM; Srikiatkhachorn, A; Supornsilpchai, W | 1 |
| Eriksson, AC; Felixsson, E; Persson, IA; Persson, K | 1 |
| Auerbach, SB; Krishnamoorthy, S; Ma, Z; Tao, R; Wei, J; Zhang, G | 1 |
| Pobbe, RL; Zangrossi, H | 1 |
| Doi, A; Ramirez, JM | 1 |
| Herth, MM; Knudsen, GM; Kramer, V; Palner, M; Rösch, F; Santini, MA | 1 |
| Estrada-González, V; Márquez-Diosdado, MI; Montes-Rodríguez, CJ; Prospéro-García, O; Soria-Gómez, E | 1 |
| Larrauri, JA; Levin, ED | 1 |
| Abe, C; Iwata, C; Morita, H; Tanaka, K | 1 |
| Cohen, MS; Fantegrossi, WE; Henson, CM; Rice, KC; Simoneau, J; Woods, JH; Zimmerman, SM | 1 |
| Fan, Y; Hong, Y; Huang, J; Jia, Y | 1 |
| MacFarlane, PM; Mitchell, GS; Vinit, S | 1 |
| Creed-Carson, M; Nobrega, JN; Oraha, A | 1 |
| Nagatani, H; Nakata, Y; Oshima, T; Saitoh, Y; Urano, A; Yokota, M | 1 |
| Jolivalt, CG; Mixcoatl-Zecuatl, T | 1 |
| Pazos, A; Pilar-Cuéllar, F; Vidal, R | 1 |
| Arai, Y; Kikuchi, T; Mitazaki, S; Nakagawasai, O; Nakaya, K; Niijima-Yaoita, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K; Watanabe, K | 1 |
| Grandt, R; Hautzel, H; Herzog, H; Müller, HW | 1 |
| Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G | 1 |
| Bennett, A; Blood, AB; Blood, Q; Dawson, A; Goyal, R; Longo, LD; Osman, NJ; Papamatheakis, DG; Pearce, WJ; Rubalcava, M; Vemulakonda, S; Vrancken, K; Wilson, SM | 1 |
| Chan, SC; Ip, MS; Lau, WK; Law, AC; Mak, JC | 1 |
| Glusa, E; Görnemann, T; Jantschak, F; Kekewska, A; Pertz, HH | 1 |
| Hackett, A; Hanania, T; Paterson, NE; Wetzler, C | 1 |
| Maraschin, M; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Chen, T; Gao, Y; Hong, Y; Quirion, R; Wang, D | 1 |
| Bachmann, R; Kometer, M; Schmidt, A; Seifritz, E; Studerus, E; Vollenweider, FX | 1 |
| Bhattacharyya, S; Panicker, MM; Raote, I | 1 |
| Chen, GS; Li, XQ; Liu, G; Liu, SB; Ma, L; Wu, YM; Xu, ZH; Yang, Q; Zhao, MG | 1 |
| Fan, F; Han, J; Liu, Y; Tian, H; Wang, W; Yan, X | 1 |
| Choi, HS; Jun, DW; Kim, DC; Kim, EK; Kwon, YI; Lee, HL; Lee, KN; Lee, OY; Yoon, BC | 1 |
| Dyssegaard, A; Ettrup, A; Gillings, N; Hansen, HD; Herth, MM; Knudsen, GM; Ratner, C | 1 |
| Corcoran, AE; Harris, MB; Richerson, GB | 1 |
| Fedotova, IuO; Frolova, HO; Ordian, NE; Soboliev, VI | 1 |
| Abman, SH; Delaney, C; Gien, J; Isenberg, N; Kailey, J; Roe, G | 1 |
| Elliott, R; Hornboll, B; Knudsen, GM; Macoveanu, J; Paulson, OB; Rowe, J; Siebner, HR | 1 |
| Couppis, MH; Juárez, P; Kennedy, CH; Lloyd, BP; May, ME; Valdovinos, MG | 1 |
| Agnati, LF; Borroto-Escuela, DO; Fuxe, K; Narvaez, M; Oflijan, J; Romero-Fernandez, W | 1 |
| Bae, YM; Cho, H; Kim, B; Kim, JG; Noh, HJ; Park, SW; Sung, DJ | 1 |
| Dong, YL; Hu, W; Li, HS; Lu, GJ; Sun, YH; Wu, SX; Yang, J; Zhao, GL; Zhu, C | 1 |
| Chacron, MJ; Larson, EA; Metzen, MG | 1 |
| Ganev, EG; Hiruma-Lima, CA; Martins, DF; Mazzardo-Martins, L; Nishijima, CM; Rocha, LR; Santos, AR | 1 |
| Chen, G; Chen, L; Fan, W; Guo, Y; Liu, L; Qian, Y; Shi, B; Xiao, L | 1 |
| Anisimova, VA; Mal'tsev, DV; Spasov, AA; Yakovlev, DS | 1 |
| Bailey, JM; Fantegrossi, WE; Gray, BW; Hansen, M; Kristensen, JL; Smith, DA | 1 |
| Gerlai, R; Markovic, S; Muraleetharan, A; Nowicki, M; Tran, S | 1 |
| Fukushima, S; Hagino, Y; Hall, FS; Igari, M; Ikeda, K; Kasahara, Y; Lesch, KP; Murphy, DL; Shen, HW; Sora, I; Uhl, GR; Yaegashi, N | 1 |
| Anastasio, NC; Cunningham, KA; Fink, LH; Fox, RG; Moeller, FG; Rice, KC | 1 |
| Hernekamp, JF; Klein, H; Kneser, U; Kremer, T; Schmidt, K | 1 |
| Hu, K; Kang, J; Mei, Y; Tu, X; Wang, N; Zuo, J | 1 |
| Hong, Y; Hu, W; Huang, BQ; Wu, B | 1 |
| Ahangari, G; Deezagi, A; Hejazi, SH | 1 |
| Beliveau, V; da Cunha-Bang, S; Dyssegaard, A; Ettrup, A; Ganz, M; Gillings, N; Jørgensen, LM; Knudsen, GM; Lehel, S; McMahon, B; Møller, K; Svarer, C | 1 |
| Cai, Q; Hong, Y; Hu, W; Wang, D; Zhang, Y | 1 |
| de Paula, BB; Leite-Panissi, CR | 1 |
| Baki, L; Drossopoulos, P; Dukat, M; Ellaithy, A; Eltit, JM; Gaitonde, SA; Glennon, RA; González-Maeso, J; Hideshima, KS; Logothetis, DE; Moreno, JL; Shah, S; Vekariya, R; Younkin, J | 1 |
| Barresi, M; Grasso, C; Li Volsi, G | 1 |
| Kraehenmann, R; Pokorny, D; Pokorny, T; Preller, KH; Seifritz, E; Vollenweider, FX; Vollenweider, L | 1 |
| Barrett, FS; Herdener, M; Janata, P; Preller, KH; Vollenweider, FX | 1 |
| de la Torre, R; Farre, M; Haijen, E; Kuypers, KPC; Olesti, E; Pastor, A; Pizarro, N; Ramaekers, JG | 1 |
| Cao, N; Gu, B; Karl-Erik, A; Ni, J; Si, J; Wang, X | 1 |
| Chen, L; Dong, J; Li, Y; Shen, Y; Wan, C; Wang, H; Wen, F; Wu, Y; Yang, T; Zeng, Z | 1 |
| Bova, S; Fusi, F; Saponara, S; Sgaragli, G; Spiga, O; Trezza, A | 1 |
| Kubilis, PS; Mitchell, GS; Perim, RR; Seven, YB | 1 |
| Makiguchi, A; Okada, T; Shioda, K; Suda, S | 1 |
| Mendonça-Junior, BA; V Fernandes, M; Zoccal, DB | 1 |
| Li, K; Liu, X; Su, R; Zhang, M | 1 |
| Garza, G; Moghaddam, B; Olson, RJ; Torrado Pacheco, A | 1 |
2 review(s) available for ketanserin and mdl 100907
| Article | Year |
|---|---|
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin | 2022 |
6 trial(s) available for ketanserin and mdl 100907
| Article | Year |
|---|---|
Evaluation of the serotonin receptor blockers ketanserin and methiothepin on the pulmonary hypertensive responses of broilers to intravenously infused serotonin.
Topics: Animals; Blood Pressure; Chickens; Hypertension, Pulmonary; Injections, Intravenous; Ketanserin; Male; Methiothepin; Poultry Diseases; Prostaglandin Endoperoxides, Synthetic; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |
Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
Topics: Administration, Oral; Adult; Affect; Brain; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Mental Recall; Pindolol; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Space Perception; Verbal Learning | 2007 |
The role of 5-HT1a and 5-HT2a receptors in attention and motor control: a mechanistic study in healthy volunteers.
Topics: Administration, Oral; Adult; Attention; Citalopram; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Ketanserin; Male; Pindolol; Psychomotor Performance; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sleep | 2007 |
Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Topics: Adult; Affect; Cerebral Cortex; Double-Blind Method; Electroencephalography; Emotions; Evoked Potentials; Female; Goals; Hallucinogens; Humans; Ketanserin; Male; Neuropsychological Tests; Psilocybin; Receptors, Serotonin; Recognition, Psychology; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala.
Topics: Adult; Amygdala; Anger; Citalopram; Facial Expression; Fear; Female; Frontal Lobe; Functional Neuroimaging; Healthy Volunteers; Humans; Ketanserin; Magnetic Resonance Imaging; Male; Neural Pathways; Photic Stimulation; Radioligand Assay; Reaction Time; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Sex Factors; Tryptophan; Visual Perception | 2013 |
Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication.
Topics: Adult; Arachidonic Acids; Double-Blind Method; Endocannabinoids; Female; Humans; Ketanserin; Male; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Polyunsaturated Alkamides; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Verbal Learning; Young Adult | 2018 |
137 other study(ies) available for ketanserin and mdl 100907
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
Topics: Animals; Brain Mapping; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Ketanserin; Male; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
Topics: Animals; Fluorobenzenes; Frontal Lobe; Ketanserin; Ligands; Male; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 1996 |
Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
Topics: Animals; Autoradiography; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Fluorobenzenes; Guanylyl Imidodiphosphate; In Situ Hybridization; In Vitro Techniques; Ketanserin; Male; Naphthalenes; Piperidines; Protein Binding; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists | 1997 |
[3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.
Topics: Aged; Aged, 80 and over; Animals; Binding Sites; Binding, Competitive; Brain; Cyclic S-Oxides; Ergolines; Female; Fluorobenzenes; Humans; In Situ Hybridization; Ketanserin; Macaca fascicularis; Male; Naphthalenes; Piperidines; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Tritium | 1998 |
Agonist and antagonist binding to rabbit cortical 5-HT2A receptors: opposite effects of magnesium.
Topics: Amphetamines; Animals; Cerebral Cortex; Fluorobenzenes; Guanylyl Imidodiphosphate; Ketanserin; Magnesium; Methysergide; Piperidines; Prazosin; Rabbits; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiperone | 1998 |
5-HT2C receptor involvement in female rat lordosis behavior.
Topics: Animals; Estradiol; Female; Fluorobenzenes; Indoles; Indophenol; Ketanserin; Ovariectomy; Piperidines; Posture; Pyridines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sexual Behavior, Animal; Ventromedial Hypothalamic Nucleus | 1999 |
Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A.
Topics: Adrenergic Uptake Inhibitors; Aggression; Animals; Brain; Corpus Striatum; Drug Evaluation, Preclinical; Fluorobenzenes; Frontal Lobe; Ketanserin; Male; Mice; Mice, Knockout; Monoamine Oxidase; Neurotransmitter Agents; Piperidines; Radioligand Assay; Serotonin Antagonists; Tetrabenazine | 1999 |
Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [3H]MDL100,907,[125I](+/-)DOI and [3H]ketanserin.
Topics: Adult; Aged; Autoradiography; Female; Fluorobenzenes; Humans; Indophenol; Iodine Radioisotopes; Ketanserin; Male; Middle Aged; Neostriatum; Piperidines; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Tritium | 1999 |
In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Topics: Amphetamines; Animals; Autoradiography; Brain Chemistry; Dose-Response Relationship, Drug; Fluorobenzenes; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Image Processing, Computer-Assisted; Indoles; Ketanserin; Male; Membrane Proteins; Piperidines; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Subcellular Fractions; Sulfur Radioisotopes | 2000 |
Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
Topics: Animals; Autoradiography; Brain; Brain Mapping; Female; Fluorobenzenes; Humans; In Situ Hybridization; Ketanserin; Macaca fascicularis; Macaca mulatta; Male; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists | 2001 |
Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
Topics: Animals; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Discrimination Learning; Dopamine; Fluorobenzenes; Ketanserin; Male; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 2001 |
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Topics: Animals; Body Temperature; Cold Temperature; Crowding; Dose-Response Relationship, Drug; Fluorobenzenes; Fluoxetine; Hallucinogens; Ketanserin; Lethal Dose 50; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Platelet Aggregation Inhibitors; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Isolation; Stereoisomerism; Telemetry | 2003 |
Discriminative stimulus properties of (+/-)-fenfluramine: the role of 5-HT2 receptor subtypes.
Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Fenfluramine; Fluorobenzenes; Indoles; Ketanserin; Male; Piperidines; Pyrazines; Pyridines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reinforcement, Psychology; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides; Thiophenes | 2003 |
Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies.
Topics: Animals; Carbon Radioisotopes; Cerebellum; Fenfluramine; Fluorobenzenes; Gene Expression; Genes, Immediate-Early; In Situ Hybridization; Ketanserin; Male; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Time Factors; Tomography, Emission-Computed | 2003 |
Selective interaction of ARF1 with the carboxy-terminal tail domain of the 5-HT2A receptor.
Topics: ADP-Ribosylation Factor 1; Amino Acid Sequence; Animals; COS Cells; Humans; Ketanserin; Molecular Sequence Data; Mutation; Protein Binding; Protein Structure, Tertiary; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2003 |
The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Topics: Animals; Aorta; Blood Pressure; Ergolines; Fenfluramine; In Vitro Techniques; Ketanserin; Male; Norfenfluramine; Prazosin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Adrenergic, alpha; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathectomy; Sympathetic Nervous System; Vasoconstriction | 2004 |
Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.
Topics: Adult; Age Factors; Anorexia Nervosa; Brain; Brain Mapping; Bulimia; Drive; Female; Fluorine Radioisotopes; Harm Reduction; Humans; Ketanserin; Protein Binding; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Thinness; Time Factors; Tomography, Emission-Computed | 2004 |
Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
Topics: Amphetamines; Animals; Indoles; Injections, Spinal; Ketanserin; Ligation; Lumbar Vertebrae; Male; Neuralgia; Nociceptors; Piperazines; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Spinal Nerves; Spiro Compounds; Sulfonamides; Thiophenes | 2004 |
Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Animals, Newborn; Benzazepines; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Ketanserin; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Tissue Proteins; Nucleus Accumbens; Oxidopamine; Phosphorylation; Prefrontal Cortex; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Antagonists | 2004 |
Diabetes inhibits the DOI-induced head-twitch response in mice.
Topics: Amphetamines; Animals; Corticosterone; Diabetes Mellitus, Experimental; Head Movements; Ketanserin; Male; Mice; Mice, Inbred ICR; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2004 |
Serotonin aggravates exercise-induced cardiac ischemia in the dog: effect of serotonin receptor antagonists.
Topics: Animals; Dogs; Endothelium, Vascular; Female; Hemodynamics; Hypercholesterolemia; Infusions, Intravenous; Ketanserin; Myocardial Ischemia; Physical Conditioning, Animal; Piperazines; Quinolines; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2004 |
Nicotinic-serotonergic drug interactions and attentional performance in rats.
Topics: Animals; Attention; Dose-Response Relationship, Drug; Drug Interactions; Female; Ketanserin; Nicotine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2005 |
Modulation of the hypoxic sensory response of the carotid body by 5-hydroxytryptamine: role of the 5-HT2 receptor.
Topics: Action Potentials; Animals; Carotid Body; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Free Radical Scavengers; Hypoxia; In Vitro Techniques; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Time Factors | 2005 |
Enhanced transcription of contractile 5-hydroxytryptamine 2A receptors via extracellular signal-regulated kinase 1/2 after organ culture of rat mesenteric artery.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Ketanserin; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Time Factors; Transcription, Genetic; Up-Regulation; Vasoconstriction | 2005 |
A serotonin receptor antagonist, but not melatonin, modulates hormonal responses to capture stress in two populations of garter snakes (Thamnophis sirtalis parietalis and Thamnophis sirtalis concinnus).
Topics: 5-Hydroxytryptophan; Adjuvants, Immunologic; Androgens; Animals; Colubridae; Corticosterone; Endocrine System; Ketanserin; Melatonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stress, Physiological | 2005 |
Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
Topics: Animals; Biguanides; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Ketanserin; Psychometrics; Quipazine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Task Performance and Analysis; Time Perception; Tropanes | 2005 |
Involvement of 5-HT2 receptors in the antinociceptive effect of Uncaria tomentosa.
Topics: Acetic Acid; Analgesics; Animals; Arginine; Atropine; Behavior, Animal; Capsaicin; Cat's Claw; Dose-Response Relationship, Drug; Formaldehyde; Ketanserin; Male; Mice; Motor Activity; Naltrexone; Pain; Pain Measurement; Phytotherapy; Plant Preparations; Prazosin; Receptors, Serotonin, 5-HT2; Reserpine; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Yohimbine | 2005 |
Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
Topics: Amphetamines; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Modulators; Dose-Response Relationship, Drug; Endocannabinoids; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Ketanserin; Male; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Kainic Acid; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists | 2005 |
Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Behavior, Animal; Benzylamines; Brain; Cyclopropanes; Dopamine; Dose-Response Relationship, Drug; Fenclonine; Flumazenil; Fluorobenzenes; Idazoxan; Indoles; Ketanserin; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Phenols; Prazosin; Punishment; Pyridines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2005 |
Maternal aggression in Wistar rats: effect of 5-HT2A/2C receptor agonist and antagonist microinjected into the dorsal periaqueductal gray matter and medial septum.
Topics: Aggression; Animals; Animals, Newborn; Female; Ketanserin; Male; Maternal Behavior; Microinjections; Periaqueductal Gray; Pregnancy; Rats; Rats, Wistar; Septum of Brain; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies.
Topics: Alkaloids; Aminopyridines; Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Female; Indole Alkaloids; Ketanserin; Male; Membrane Potentials; Methoxydimethyltryptamines; Mianserin; Mice; Mice, Inbred ICR; Motor Activity; Oocytes; Oxindoles; Patch-Clamp Techniques; Piperazines; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Xenopus | 2005 |
Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain.
Topics: Animals; Binding Sites; Binding, Competitive; Denervation; Disease Models, Animal; Drug Interactions; Hyperalgesia; Ketanserin; Ligation; Male; Neuralgia; Pain Threshold; Peripheral Nerves; Peripheral Nervous System Diseases; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sciatic Neuropathy; Sensory Receptor Cells; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Succinates | 2005 |
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
Topics: Animals; Binding, Competitive; Brain; Carbon Radioisotopes; Fluorine Radioisotopes; Fluorobenzenes; Ketanserin; Male; Piperidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2005 |
Stimulation of 5-HT 1A receptors increases the seizure threshold for picrotoxin in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Drug Administration Schedule; Drug Therapy, Combination; Ketanserin; Male; Mice; Mice, Inbred CBA; Picrotoxin; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Seizures; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Stress, Physiological; Swimming | 2005 |
Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
Topics: Amphetamines; Animals; Association Learning; Brain; Discrimination Learning; Female; Fluorobenzenes; Injections, Intraperitoneal; Injections, Subcutaneous; Ketanserin; Piperidines; Psychophysics; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists; Time Perception | 2006 |
Rewarding properties of 1-benzylpiperazine, a new drug of abuse, in rats.
Topics: Animals; Behavior, Animal; Benzazepines; Conditioning, Psychological; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Ketanserin; Male; Piperidines; Psychotropic Drugs; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Reward; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance-Related Disorders; Tropanes | 2006 |
Endogenous 5-HT2B receptor activation regulates neonatal respiratory activity in vitro.
Topics: Animals; Animals, Newborn; In Vitro Techniques; Indoles; Ketanserin; Kinetics; Mice; Microinjections; Organic Chemicals; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Respiration; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Thiophenes | 2006 |
Cardiac baroreflex facilitation evoked by hypothalamus and prefrontal cortex stimulation: role of the nucleus tractus solitarius 5-HT2A receptors.
Topics: Animals; Atenolol; Atropine Derivatives; Baroreflex; Brain; Electric Stimulation; Fluorobenzenes; Heart; Ketanserin; Male; Microinjections; Neural Inhibition; Neural Pathways; Parasympatholytics; Piperidines; Prefrontal Cortex; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Solitary Nucleus; Stimulation, Chemical; Sympatholytics | 2006 |
Differential regulation of the left and right coronary arteries of swine.
Topics: Animals; Coronary Vessels; In Vitro Techniques; Ketanserin; Male; Potassium Chloride; Propranolol; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Swine; Vasoconstriction | 2006 |
Contribution of 5-HT2A receptor in nematode infection-induced murine intestinal smooth muscle hypercontractility.
Topics: Animals; Disease Models, Animal; Female; Gene Expression; Ketanserin; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscle Hypertonia; Muscle, Smooth; Nematode Infections; Nippostrongylus; Polymerase Chain Reaction; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |
Persistence of eupnea and gasping following blockade of both serotonin type 1 and 2 receptors in the in situ juvenile rat preparation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Decerebrate State; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoglossal Nerve; Ischemia; Ketanserin; Lung; Methysergide; Peripheral Nerves; Phrenic Nerve; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT1; Respiratory Mechanics; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors; Vagus Nerve | 2007 |
Effect of 5-HT(2) receptor blockade on cadmium-induced acute toxicity.
Topics: Animals; Apoptosis; Cadmium; Disease Models, Animal; In Situ Nick-End Labeling; Ketanserin; Liver Failure, Acute; Male; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome | 2007 |
Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Topics: Animals; Antibodies, Monoclonal; Antihypertensive Agents; Baroreflex; Blood Pressure; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Immunotoxins; Ketanserin; N-Glycosyl Hydrolases; Neurons; Plant Proteins; Rats; Rats, Inbred SHR; Receptor, Serotonin, 5-HT2A; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 2007 |
Pregnant rats treated with a serotonin precursor have reduced fetal weight and lower plasma volume and kallikrein levels.
Topics: 5-Hydroxytryptophan; Aldosterone; Animals; Blood Pressure; Creatinine; Disease Models, Animal; Female; Fetal Weight; Kallikreins; Ketanserin; Plasma Volume; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists | 2007 |
The involvement of serotonin receptors in suanzaorentang-induced sleep alteration.
Topics: Animals; Drugs, Chinese Herbal; Ketanserin; Piperazines; Plant Extracts; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sleep; Time Factors | 2007 |
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Calcium Signaling; Calcium-Binding Proteins; Cardiac Myosins; Cardiotonic Agents; Coronary Vessels; Disease Models, Animal; Heart Failure; Indoles; Isoproterenol; Ketanserin; Ligation; Male; Myocardial Contraction; Myocardial Infarction; Myocytes, Cardiac; Myosin Light Chains; Phosphorylation; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT4; Sarcoplasmic Reticulum; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Time Factors; Troponin I; Ventricular Function | 2007 |
Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test.
Topics: Aminopyridines; Amphetamines; Animals; Conditioning, Operant; Ethylamines; Fluorobenzenes; Impulsive Behavior; Indoles; Ketanserin; Male; Mice; Mice, Inbred C57BL; Piperidines; Quinolines; Rats; Reaction Time; Serial Learning; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Species Specificity | 2007 |
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.
Topics: Adult; Arousal; Attention; Double-Blind Method; Drug Combinations; Female; Hallucinogens; Humans; Ketanserin; Male; Psilocybin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Vision Disparity; Vision, Binocular | 2007 |
Evidence for the involvement of 5-HT2A receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice.
Topics: Amphetamines; Animals; Capillary Permeability; Female; Gastrointestinal Transit; Intestines; Ketanserin; Leukocytes; Lipid Peroxidation; Lung; Malondialdehyde; Mesenteric Artery, Superior; Mice; Peroxidase; Platelet Aggregation; Receptor, Serotonin, 5-HT2A; Reperfusion Injury; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha | 2007 |
Maintenance of gasping and restoration of eupnea after hypoxia is impaired following blockers of alpha1-adrenergic receptors and serotonin 5-HT2 receptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amphetamines; Animals; Decerebrate State; Diaphragm; Dioxanes; Disease Models, Animal; Dose-Response Relationship, Drug; Hypoxia; Ketanserin; Methoxamine; Methysergide; Periodicity; Phrenic Nerve; Rats; Receptors, Adrenergic, alpha-1; Receptors, Serotonin, 5-HT2; Respiratory Mechanics; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Total synthesis and evaluation of [18F]MHMZ.
Topics: Animals; Binding, Competitive; Brain; Fluorine Radioisotopes; Fluorobenzenes; Isotope Labeling; Ketanserin; Kinetics; Piperidines; Radioligand Assay; Radionuclide Imaging; Radiopharmaceuticals; Rats; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2008 |
Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT2A receptor function.
Topics: Amphetamines; Analysis of Variance; Animals; Brain; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Fluorobenzenes; Gene Expression; Genetic Variation; Head Movements; Ketanserin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Piperidines; Protein Binding; Proto-Oncogene Proteins c-fos; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists | 2008 |
Antidepressant activity of standardised extract of Marsilea minuta Linn.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Female; Flunitrazepam; Hindlimb Suspension; Ketanserin; Male; Marsileaceae; Mice; Plant Extracts; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Swimming | 2008 |
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.
Topics: Binding Sites; Cell Line; Cell Line, Tumor; DNA-Binding Proteins; Ethylamines; Humans; Intracellular Signaling Peptides and Proteins; Iodine Radioisotopes; Iodobenzenes; Ketanserin; Nuclear Proteins; Radioligand Assay; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Tritium; Tumor Necrosis Factor alpha-Induced Protein 3 | 2008 |
Effects of selective serotonin2 ligands on behaviors evoked by stress in the rat.
Topics: Animals; Behavior, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Ketanserin; Male; Motor Activity; Pain Measurement; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Spiperone; Stress, Psychological; Vocalization, Animal | 2008 |
Human embryonic stem cell-derived oligodendrocyte progenitor cells express the serotonin receptor and are susceptible to JC virus infection.
Topics: Antibodies, Monoclonal; Antigens; Biomarkers; Cell Line; Embryonic Stem Cells; Fetus; Humans; JC Virus; Ketanserin; Leukoencephalopathy, Progressive Multifocal; Oligodendroglia; Proteoglycans; Receptor, Serotonin, 5-HT2A; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2008 |
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat.
Topics: Amphetamine; Animals; Binding, Competitive; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Indoles; Ketanserin; Male; Positron-Emission Tomography; Protein Binding; Pyridines; Raclopride; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2008 |
Prenatal activation of 5-HT2A receptor induces expression of 5-HT1B receptor in phrenic motoneurons and alters the organization of their premotor network in newborn mice.
Topics: Amphetamines; Animals; Animals, Newborn; Embryo, Mammalian; Female; Ketanserin; Mice; Mice, Inbred C3H; Mice, Transgenic; Motor Neurons; Nerve Net; Phrenic Nerve; Pregnancy; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ketanserin; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Self Administration; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tobacco Use Disorder | 2008 |
Serotonin 5-HT(2) and 5-HT(1A)-like receptors differentially modulate aggressive behaviors in Drosophila melanogaster.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Amphetamines; Analysis of Variance; Animals; Drosophila melanogaster; Drosophila Proteins; Drug Interactions; Female; Gene Expression; Ketanserin; Male; Membrane Glycoproteins; Motor Activity; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior | 2009 |
Behavioral pharmacological properties after recovery from the loss of righting reflex induced by benzodiazepine receptor agonists in mice.
Topics: Animals; Azepines; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Flunitrazepam; GABA Agonists; GABA-A Receptor Agonists; Hypnotics and Sedatives; Ketanserin; Male; Mice; Mice, Inbred Strains; Pyridines; Reflex; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Time Factors; Zolpidem | 2008 |
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
Topics: Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Electroshock; Fluorobenzenes; Hallucinogens; Ketanserin; Macaca mulatta; Phenethylamines; Piperidines; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Regression Analysis; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload.
Topics: Animals; Aorta; Blood Pressure; Cardiomegaly; Fibrosis; Fluorobenzenes; Gene Deletion; Gene Expression Regulation; Heart Ventricles; Ketanserin; Mice; Mice, Knockout; Monoamine Oxidase; Myocardium; Piperidines; Pressure; Receptors, Serotonin; Serotonin; Stress, Physiological; Ultrasonography | 2009 |
Enhanced 5-HT(2A) receptors in brain stem and ALDH activity in brain stem and liver: 5-HT(2A) regulation on ALDH in primary hepatocytes cultures in vitro.
Topics: Aldehyde Dehydrogenase; Animals; Brain Stem; Ethanol; Fluorobenzenes; Hepatocytes; Ketanserin; Liver; Piperidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin | 2009 |
Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Body Temperature; Clorgyline; Cyproheptadine; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ketanserin; Male; Microdialysis; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Syndrome | 2009 |
Effects of acute intra-cerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats.
Topics: Amygdala; Analysis of Variance; Animals; Frontal Lobe; Impulsive Behavior; Indophenol; Ketanserin; Ligands; Male; Microinjections; Neuropsychological Tests; Psychomotor Performance; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Topics: Analgesics, Opioid; Anesthetics, Dissociative; Animals; Conditioning, Operant; Discrimination, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Ketamine; Ketanserin; Male; Morphine; Phencyclidine; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |
Inhibitory effect of serotonin antagonists on JC virus propagation in a carrier culture of human neuroblastoma cells.
Topics: Cell Line, Tumor; Down-Regulation; Humans; JC Virus; Ketanserin; Neuroblastoma; Receptor, Serotonin, 5-HT2A; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Virus Cultivation; Virus Replication | 2009 |
Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
Topics: Amphetamines; Animals; Behavior, Animal; Decision Making; Dose-Response Relationship, Drug; Drug Interactions; Ketanserin; Male; Maze Learning; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Reinforcement Schedule; Reward; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2009 |
Serotonergic mechanisms on breathing modulation in the rat locus coeruleus.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Amphetamines; Animals; Hydroxyindoleacetic Acid; Hypercapnia; Idazoxan; Ketanserin; Locus Coeruleus; Male; Microinjections; Piperazines; Pulmonary Ventilation; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Respiration; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2010 |
Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature Regulation; Central Nervous System Stimulants; Corticosterone; Drug Administration Schedule; Fever; Hippocampus; Ketanserin; Male; Methamphetamine; Periodicity; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Stress, Psychological | 2010 |
Imaging cortical dopamine D1 receptors using [11C]NNC112 and ketanserin blockade of the 5-HT 2A receptors.
Topics: Adult; Animals; Benzazepines; Benzofurans; Brain; Carbon Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Ketanserin; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Receptors, Dopamine D1; Serotonin 5-HT2 Receptor Antagonists; Staining and Labeling; Young Adult | 2010 |
Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Cerebral Cortex; Cerebrovascular Circulation; Disease Models, Animal; Headache Disorders, Secondary; Hyperalgesia; Inflammation; Inflammation Mediators; Ketanserin; Male; Neuronal Plasticity; Nociceptors; Pain Measurement; Pain Threshold; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Trigeminal Nerve | 2010 |
Horse chestnut extract contracts bovine vessels and affects human platelet aggregation through 5-HT(2A) receptors: an in vitro study.
Topics: Adenosine Diphosphate; Adrenergic alpha-1 Receptor Antagonists; Aesculus; Angiotensin II Type 1 Receptor Blockers; Animals; Cattle; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Ketanserin; Mesenteric Arteries; Mesenteric Veins; Muscle Contraction; Muscle, Smooth, Vascular; Plant Bark; Plant Extracts; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, Serotonin, 5-HT2A; Seeds; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Involvement of 5-HT2A receptors in the serotonin (5-HT) syndrome caused by excessive 5-HT efflux in rat brain.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Brain; Clorgyline; Hypothermia, Induced; Ketanserin; Male; Microdialysis; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Syndrome | 2010 |
The lateral habenula regulates defensive behaviors through changes in 5-HT-mediated neurotransmission in the dorsal periaqueductal gray matter.
Topics: Animals; Avoidance Learning; Habenula; Kainic Acid; Ketanserin; Male; Maze Learning; Motor Activity; Neurons; Periaqueductal Gray; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Synaptic Transmission | 2010 |
State-dependent interactions between excitatory neuromodulators in the neuronal control of breathing.
Topics: Action Potentials; Adrenergic alpha-1 Receptor Antagonists; Animals; Animals, Newborn; Electric Stimulation; Electromyography; Hypoglossal Nerve; In Vitro Techniques; Isoindoles; Ketanserin; Locus Coeruleus; Mice; Microinjections; Neural Inhibition; Neural Pathways; Neurokinin-1 Receptor Antagonists; Neurons; Neurotransmitter Agents; Piperidines; Raphe Nuclei; Receptors, Adrenergic, alpha-1; Receptors, Neurokinin-1; Receptors, Serotonin, 5-HT2; Respiration; Respiratory Center; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2010 |
Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.
Topics: Binding, Competitive; Combinatorial Chemistry Techniques; Fluorobenzenes; Hydrophobic and Hydrophilic Interactions; Ketanserin; Ligands; Phenols; Piperidines; Protein Binding; Pyridines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors.
Topics: Aminopyridines; Animals; Eating; Feeding Behavior; Hyperphagia; Hypothalamus; Indoles; Ketanserin; Male; Motor Activity; Nucleus Accumbens; Oleic Acids; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists | 2010 |
PPI deficit induced by amphetamine is attenuated by the histamine H1 antagonist pyrilamine, but is exacerbated by the serotonin 5-HT2 antagonist ketanserin.
Topics: Acoustic Stimulation; Amphetamine; Animals; Behavior, Animal; Central Nervous System Stimulants; Female; Histamine H1 Antagonists; Inhibition, Psychological; Ketanserin; Physical Stimulation; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex, Startle; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Vestibular-mediated increase in central serotonin plays an important role in hypergravity-induced hypophagia in rats.
Topics: Animals; Arsanilic Acid; Body Weight; Drinking; Eating; Feeding Behavior; Hypergravity; Ketanserin; Male; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Time Factors; Up-Regulation; Vestibular Nuclei | 2010 |
Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Hallucinogens; Head; Indoles; Ketanserin; Male; Mice; Mice, Inbred Strains; Movement; Piperidines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Sulfonamides | 2010 |
Antagonism of 5-HT(2A) receptors inhibits the expression of pronociceptive mediator and enhances endogenous opioid mechanism in carrageenan-induced inflammation in rats.
Topics: Animals; beta-Endorphin; Calcitonin Gene-Related Peptide; Carrageenan; Ganglia, Spinal; Inflammation; Ketanserin; Male; Pain; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Opioid, mu; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord | 2011 |
Serotonin 2A and 2B receptor-induced phrenic motor facilitation: differential requirement for spinal NADPH oxidase activity.
Topics: Acetophenones; Action Potentials; Amphetamines; Animals; Indoles; Injections, Spinal; Ketanserin; Male; NADPH Oxidases; Onium Compounds; Phrenic Nerve; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Thiophenes | 2011 |
Effects of 5-HT(2A) and 5-HT(2C) receptor antagonists on acute and chronic dyskinetic effects induced by haloperidol in rats.
Topics: Aminopyridines; Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dyskinesia, Drug-Induced; Fluorobenzenes; Gene Expression Regulation; Haloperidol; Immunohistochemistry; In Situ Hybridization; Indoles; Ketanserin; Male; Mouth; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; RNA, Messenger; Serotonin Antagonists | 2011 |
Blockade of 5-HT(2A) and/or 5-HT(2C) receptors modulates sevoflurane-induced immobility.
Topics: Anesthetics, Inhalation; Animals; Immobilization; Indoles; Ketanserin; Male; Methyl Ethers; Pyridines; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Sevoflurane | 2011 |
A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.
Topics: Amphetamines; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Hyperalgesia; Ketanserin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Thiophenes | 2011 |
Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Fluoxetine; Hippocampus; Ketanserin; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Swimming | 2012 |
p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.
Topics: 5,7-Dihydroxytryptamine; Acoustic Stimulation; Analysis of Variance; Animals; Autoradiography; Brain; Dose-Response Relationship, Drug; Fenclonine; Fluorobenzenes; Inhibition, Psychological; Ketanserin; Male; Mice; p-Hydroxyamphetamine; Piperidines; Reflex, Startle; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2011 |
Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin.
Topics: Brain Mapping; Cognition; Cross-Over Studies; Fluorine Radioisotopes; Frontal Lobe; Humans; Ketanserin; Male; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2011 |
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fetus; Fluoxetine; Hemodynamics; Hypertension, Pulmonary; Hysterotomy; Indoles; Ketanserin; Lung; Oxadiazoles; Piperazines; Pregnancy; Pulmonary Artery; Pyridines; Receptors, Serotonin; rho-Associated Kinases; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep; Vascular Resistance | 2011 |
Preservation of serotonin-mediated contractility in adult sheep pulmonary arteries following long-term high-altitude hypoxia.
Topics: Altitude Sickness; Animals; Benzamides; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Female; In Vitro Techniques; Ketanserin; Microscopy, Confocal; Muscle Contraction; Muscle, Smooth, Vascular; Myography; Nickel; Pulmonary Artery; Pyridines; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sheep; Sodium-Calcium Exchanger; Spermine; Time Factors; TRPC Cation Channels; TRPM Cation Channels | 2011 |
The role of MAPK and Nrf2 pathways in ketanserin-elicited attenuation of cigarette smoke-induced IL-8 production in human bronchial epithelial cells.
Topics: Anti-Inflammatory Agents; Antioxidants; Bronchi; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Glutathione; Humans; Interleukin-8; Ketanserin; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-E2-Related Factor 2; Oxidation-Reduction; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Receptor, Serotonin, 5-HT2A; RNA Interference; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Smoke; Smoking; Time Factors; Transfection; Up-Regulation | 2012 |
Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Animals; Aortic Valve; Blood Vessels; Cells, Cultured; Collagen; Coronary Vessels; Dose-Response Relationship, Drug; Heart Valves; Humans; In Vitro Techniques; Inhibitory Concentration 50; Ketanserin; Kinetics; Lisuride; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitral Valve; Phosphorylation; Platelet Aggregation; Pulmonary Artery; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sus scrofa; Vasoconstriction; Vasodilation | 2012 |
Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat.
Topics: Adrenergic Uptake Inhibitors; Aminopyridines; Animals; Atomoxetine Hydrochloride; Choice Behavior; Dopamine Uptake Inhibitors; Impulsive Behavior; Indoles; Ketanserin; Male; Methylphenidate; Propylamines; Rats; Rats, Long-Evans; Reaction Time; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Coumaric Acids; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Immobility Response, Tonic; Ketanserin; Male; Mice; Motor Activity; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sertraline | 2012 |
Inhibition of SNL-induced upregulation of CGRP and NPY in the spinal cord and dorsal root ganglia by the 5-HT(2A) receptor antagonist ketanserin in rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Denervation; Disease Models, Animal; Ganglia, Spinal; Hyperalgesia; Immunohistochemistry; Ketanserin; Male; Neuralgia; Neuronal Plasticity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord; Spinal Nerves; Up-Regulation | 2012 |
Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation.
Topics: Amphetamines; Animals; Clozapine; Dopamine; Drug Partial Agonism; Endocytosis; Enzyme Activation; HEK293 Cells; Humans; Ketanserin; Ligands; Phosphorylation; Protein Kinase C; Protein Phosphatase 2; Protein Transport; Rats; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction | 2013 |
Deficits in LTP induction by 5-HT2A receptor antagonist in a mouse model for fragile X syndrome.
Topics: Animals; Blotting, Western; Cells, Cultured; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gyrus Cinguli; Humans; Ketanserin; Long-Term Potentiation; Male; Mice; Mice, 129 Strain; Mice, Knockout; Patch-Clamp Techniques; Pyrrolidines; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Antagonists; Synaptic Potentials | 2012 |
Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Ketanserin; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Pulmonary Artery; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Random Allocation; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2013 |
5-HT2A receptor antagonists inhibit hepatic stellate cell activation and facilitate apoptosis.
Topics: Actins; Animals; Apoptosis; Cell Line; Cell Survival; Collagen Type I; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Humans; Ketanserin; Liver Cirrhosis, Experimental; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2A; Ritanserin; RNA, Messenger; Serotonin 5-HT2 Receptor Antagonists; Smad2 Protein; Smad3 Protein; Succinates; Thioacetamide; Time Factors; Transforming Growth Factor beta; Wound Healing | 2013 |
Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Topics: Animals; Brain; Fluorine Radioisotopes; Fluorobenzenes; Ketanserin; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Swine; Tissue Distribution; Tritium | 2013 |
Serotonergic mechanisms are necessary for central respiratory chemoresponsiveness in situ.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain Stem; Hypercapnia; Ketanserin; Phrenic Nerve; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Respiratory Mechanics; Serotonergic Neurons; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists | 2013 |
[Involvement of some subtypes of 5-HT2-receptors in affective behavior in female rats].
Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Anxiety; Depression; Estrogens; Estrus; Female; Injections, Intraperitoneal; Ketanserin; Piperazines; Proestrus; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn.
Topics: Adult; Animals; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Familial Primary Pulmonary Hypertension; Fetus; Gene Expression; Humans; Hypertension, Pulmonary; Infant, Newborn; Ketanserin; Lung; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep, Domestic; Tryptophan Hydroxylase; Vascular Resistance | 2013 |
Serotonin₂A/C receptors mediate the aggressive phenotype of TLX gene knockout mice.
Topics: Aggression; Animals; Behavior, Animal; Clozapine; Ketanserin; Male; Mice; Mice, Knockout; Motor Activity; Phenotype; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Cytoplasmic and Nuclear; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Topics: Amphetamines; Animals; Basal Ganglia; Gene Expression Regulation; Genes, Reporter; Hallucinogens; HEK293 Cells; Humans; Ketanserin; Luciferases; Lysergic Acid Diethylamide; Male; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase.
Topics: 4-Aminopyridine; Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Ketanserin; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spiperone; src-Family Kinases; Vasoconstriction | 2013 |
The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Duloxetine Hydrochloride; Hyperalgesia; Idazoxan; Injections, Intraperitoneal; Injections, Spinal; Ketanserin; Male; Microdialysis; Norepinephrine; Pain, Postoperative; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord; Thiophenes | 2014 |
Serotonin modulates electrosensory processing and behavior via 5-HT2-like receptors.
Topics: Action Potentials; Animals; Electric Organ; Electric Stimulation; Gymnotiformes; Ketanserin; Microelectrodes; Motor Activity; Perception; Pyramidal Cells; Receptors, Serotonin; Rhombencephalon; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Tissue Culture Techniques | 2014 |
Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain.
Topics: Acute Pain; Acyclic Monoterpenes; Analgesics; Animals; Capsaicin; Chronic Pain; Excitatory Amino Acids; Formaldehyde; Glutamic Acid; Hyperalgesia; Ischemia; Ketanserin; Male; Mice; Monoterpenes; Neuralgia; Pain, Postoperative; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Stomach Ulcer; Substance P; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |
Ketanserin, a serotonin 2A receptor antagonist, alleviates ischemia-related biliary fibrosis following donation after cardiac death liver transplantation in rats.
Topics: Animals; Biliary Tract Diseases; Cells, Cultured; Drug Evaluation, Preclinical; Fibroblasts; Fibrosis; Ischemia; Ketanserin; Liver; Liver Transplantation; Male; Postoperative Complications; Rats, Sprague-Dawley; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation | 2014 |
Effect of 5-HT(2A) receptor antagonists on blood flow in the carotid vessels upon elevation of serotonin level.
Topics: Animals; Animals, Outbred Strains; Carotid Arteries; Drug Evaluation, Preclinical; Ketanserin; Male; Rats; Regional Blood Flow; Ritanserin; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction | 2014 |
Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Topics: Amphetamines; Animals; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Head Movements; Ketanserin; Male; Mice; Phenethylamines; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2015 |
Serotonin antagonists induce anxiolytic and anxiogenic-like behavior in zebrafish in a receptor-subtype dependent manner.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Ketanserin; Ondansetron; Piperazines; Pyridines; Receptors, Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Zebrafish | 2014 |
Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
Topics: Animals; Behavior, Animal; Benzamides; Central Nervous System Stimulants; Dopamine; Female; Ketanserin; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Motor Activity; Oxadiazoles; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins | 2015 |
Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System.
Topics: Animals; Choice Behavior; Dimethoxyphenylethylamine; Fluorobenzenes; Head Movements; Immunoprecipitation; Impulsive Behavior; Individuality; Ketanserin; Male; Piperidines; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Tritium | 2015 |
5-HT2a receptor antagonism reduces burn-induced macromolecular efflux in rats.
Topics: Animals; Burns; Edema; Endothelium, Vascular; Hemodynamics; Ketanserin; Leukocytes; Mesentery; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serum Albumin | 2015 |
Effect of Systemic Application of 5-Hydroxytryptamine on Hypoglossal Nerve Discharge in Anesthetized Rats.
Topics: Action Potentials; Anesthesia, General; Animals; Carotid Body; Hypoglossal Nerve; Injections, Intravenous; Ketanserin; Long-Term Potentiation; Male; Nerve Tissue Proteins; Nodose Ganglion; Oxidative Stress; Phosphorylation; Protein Isoforms; Protein Kinase C; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2A; Respiration; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Staurosporine | 2015 |
[Effects of blockade of 5-HT2A receptors in inflammatory site on complete Freund's adjuvant-induced chronic hyperalgesia and neuropeptide Y expression in the spinal dorsal horn in rats].
Topics: Animals; Freund's Adjuvant; Ganglia, Spinal; Hot Temperature; Hyperalgesia; Inflammation; Ketanserin; Neuropeptide Y; Pain; Pain Measurement; Rats; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord Dorsal Horn | 2015 |
Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Gene Expression; Humans; Indoles; Ketanserin; MCF-7 Cells; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Tropisetron | 2015 |
Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Topics: Benzylamines; Brain; Carbon Radioisotopes; Female; Fluorine Radioisotopes; Humans; Ketanserin; Male; Neuroimaging; Phenethylamines; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Young Adult | 2016 |
Blockade of 5-HT2A receptors at the site of inflammation inhibits activation of spinal dorsal horn neurons in rats.
Topics: Animals; Carrageenan; Gene Expression Regulation; Inflammation; Ketanserin; Male; NADH Dehydrogenase; Nitric Oxide Synthase; Posterior Horn Cells; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord | 2016 |
Distinct effect of 5-HT1A and 5-HT2A receptors in the medial nucleus of the amygdala on tonic immobility behavior.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Corticomedial Nuclear Complex; Fear; Guinea Pigs; Immobility Response, Tonic; Ketanserin; Male; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.
Topics: Animals; Barium; Calcium; G Protein-Coupled Inwardly-Rectifying Potassium Channels; HEK293 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Ketanserin; Membrane Potentials; Mutation; Oocytes; Protein Binding; Receptor, Serotonin, 5-HT2A; Risperidone; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tritium; Xenopus laevis | 2016 |
Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Iontophoresis; Ketanserin; Male; Medulla Oblongata; Neurons; Piperazines; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation.
Topics: Dopamine; Healthy Volunteers; Humans; Ketanserin; Lysergic Acid Diethylamide; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2017 |
Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music.
Topics: Auditory Perception; Brain; Brain Mapping; Double-Blind Method; Emotions; Hallucinogens; Humans; Ketanserin; Lysergic Acid Diethylamide; Magnetic Resonance Imaging; Memory; Music; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists | 2018 |
Effect of 5-HT
Topics: Animals; Ketanserin; Male; Motor Neurons; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Urethane; Urethra; Urinary Bladder; Urination | 2018 |
Serotonin receptors 5-HTR2A and 5-HTR2B are involved in cigarette smoke-induced airway inflammation, mucus hypersecretion and airway remodeling in mice.
Topics: Airway Remodeling; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Humans; Injections, Intraperitoneal; Ketanserin; Lung; Male; Mice; Mucus; Nicotiana; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Quercetin; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Respiratory Mucosa; Serotonin 5-HT2 Receptor Antagonists; Smoke; Specific Pathogen-Free Organisms | 2020 |
Ritanserin blocks Ca
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Binding Sites; Calcium Channels, L-Type; Electrophysiological Phenomena; Ketanserin; Male; Molecular Docking Simulation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Protein Binding; Rats, Wistar; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction | 2020 |
Hypoxia-induced hypotension elicits adenosine-dependent phrenic long-term facilitation after carotid denervation.
Topics: Adenosine; Animals; Arterial Pressure; Blood Gas Analysis; Carotid Body; Denervation; Hypotension; Hypoxia; Ketanserin; Long-Term Potentiation; Male; Phenylephrine; Phrenic Nerve; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Serotonin 5-HT2 Receptor Antagonists; Spinal Cord | 2020 |
Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats.
Topics: Animals; Benzazepines; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Hyperthermia; Ketanserin; Male; Rats; Rats, Wistar; Risperidone; Ritanserin; Serotonin 5-HT2 Receptor Antagonists | 2020 |
Acute intermittent hypoxia evokes ventilatory long-term facilitation and active expiration in unanesthetized rats.
Topics: Animals; Disease Models, Animal; Hypoxia; Ketanserin; Male; Pulmonary Ventilation; Rats; Rats, Sprague-Dawley; Respiratory Mechanics; Serotonin 5-HT2 Receptor Antagonists; Tidal Volume | 2021 |
Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine.
Topics: Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Ketanserin; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Olanzapine; Receptor, Serotonin, 5-HT2A | 2023 |
Acute psilocybin enhances cognitive flexibility in rats.
Topics: Animals; Anxiety; Cognition; Female; Hallucinogens; Ketanserin; Male; Psilocybin; Rats; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2023 |